Non-animal models at inflection point, but hedging expectations crucial

While NAMs could revolutionise preclinical development, experts warn that they won’t phase out animal testing for “a long time”. While NAMs could revolutionise preclinical development, experts warn that they won’t phase out animal testing for “a long time”. Experts at a Westminster Health Forum seminar noted that NAMs will have a place as a complementary approach to animal testing in preclinical toxicology, rather than outright replacing it, for the foreseeable future. Credit: Hugethank / Shutterstock.com. In recent years, there has been a strong global push to evolve the way researchers conduct preclinical testing, with government organisations, industry members and life…

Source: Clinical Trials Arena